Evidence map›Paper›PMID 42446807›Full record

ArticleJournal of computer-aided molecular design2026

HighDB: a structure-annotated cyclic peptide database for comparative analysis, template retrieval, and design-oriented applications.

Yiqi Xu, Ning Zhu, Tianfeng Shang, Shiyi Yao, Hongliang Duan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yiqi XuCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
Ning ZhuFaculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China.
Tianfeng ShangAI Department, Shenzhen Highslab Therapeutics. Inc, Shenzhen, 518000, China.
Shiyi YaoCollege of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
Hongliang DuanFaculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China. hduan@mpu.edu.mo.

Funding

Macao Science and Technology Development Fund 0151/2024/RIA2
6 · The paper itself

Abstract

Cyclic peptides are increasingly explored as modulators of difficult-to-drug targets and protein-protein interactions, yet structure-centered resources with standardized, computable annotations remain limited. Here we present HighDB, a curated database of experimentally resolved cyclic peptide structures collected from the Protein Data Bank and related literature. The current release contains 2,504 entries annotated at the PDB-chain level and harmonized across cyclization type, ring number, overall secondary structure, peptide naturalness, and complex context. HighDB combines keyword retrieval, multidimensional filtering, sequence-similarity search, and interactive three-dimensional visualization to support comparative structural analysis, dataset construction, template retrieval, and design-oriented exploration of cyclic peptide space. In addition to database development, we provide a unified annotation framework for topological and conformational descriptors and compare HighDB with representative cyclic peptide resources, showing broader annotation coverage and the largest collection of experimentally resolved cyclic peptide structures among the databases examined. HighDB is freely accessible for academic use at http://highdb.duanlab.ac/ .

Indexed as

Databases, ProteinPeptides, CyclicDrug DesignProtein ConformationPeptides, CyclicBenchmark constructionCyclic peptide databaseStructural bioinformaticsTemplate retrievalTopology annotation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.